Introduction: Cannabidiol (CBD) is the second most abundant Phytocannabinoid in
Cannabis extracts. CBD has a binding affinity for several cannabinoid and cannabinoid …

This systematic review examine the biological effects of CBD, a major component of
therapeutic Cannabis, on human pathological and cancer cell populations of integumentary …

Colorectal cancer is the third leading cause of cancer incidence and mortality in the United
States. Cannabidiol (CBD), the second most abundant phytocannabinoid in Cannabis …

There is currently a growing interest in the use of cannabidiol (CBD) to alleviate the
symptoms caused by cancer, including pain, sleep disruption, and anxiety. CBD is often self …

Simple Summary Ovarian cancer is the most lethal gynecological malignancy. Cancer stem
cells have been implicated in tumor initiation, progression, and invasion, as well as tumor …

Cannabinoids have been utilized for recreational and therapeutic purposes for over 4,000
years. As the primary ingredient in exogenous cannabinoids, Cannabidiol (CBD) has drawn …

Simple Summary Mesothelioma is a deadly disease with few treatment options.
Phytocannabinoids derived from the cannabis plant are garnering interest for their anti …

Plant-based, synthetic, and endogenous cannabinoids have been shown to control a
diverse array of biological processes, including regulation of cell fate across cancers. Their …

Cannabinoids have incited scientific interest in different conditions, including malignancy,
due to increased exposure to cannabis. Furthermore, cannabinoids are increasingly used to …

Background Cannabidiol (CBD), a nonpsychoactive cannabinoid with a low toxicity profile,
has been shown to produce antitumor activity across cancers in part through selective …